£140K
Orthopaedic Research UK provided the pre-seed funding through the newly launched Ronald Furlong Fund.
Renovos creates nanoclay gel technology to transform orthopaedic surgery and regenerative medicine.
Renovos develops regenerative medicine solutions using proprietary nanoclay gel technology to improve orthopaedic surgery outcomes. The company harnesses innovative delivery platforms to enhance tissue repair and bone healing.
Richard OC Oreffo
Founder and CSO
Orthopaedic Research UK provided the pre-seed funding through the newly launched Ronald Furlong Fund.